Effect of sublingual immunotherapy on level of cytokines in PBMCs of patients with allergic asthma

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 31, Issue 3, 2011, Pages 376-378

  Wang, Zhongxi ^a   Li, Wenjing ^a   Chen, Huan ^a   Zhang, Wei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Allergic asthma; Dust mite; IFN ; IL 4; Sublingual immunotherapy

Indexed keywords

GAMMA INTERFERON; HOUSE DUST ALLERGEN; INTERLEUKIN 4;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MALE; METABOLISM; METHODOLOGY; MONONUCLEAR CELL; SUBLINGUAL DRUG ADMINISTRATION; TH1 TH2 BALANCE;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; FEMALE; HUMANS; IMMUNOTHERAPY; INTERFERON-GAMMA; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MALE; TH1-TH2 BALANCE; YOUNG ADULT;

EID: 80455167876     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-011-0384-5     Document Type: Article

References (10)

1. Asthma Group of Respirology Branch of Chinese Medical Association. Prevention Guide of Bronchial Asthma (including definition, diagnosis, treatment and management of bronchial asthma). Zhong Hua Jie He He Hu Xi Za Zhi (Chinese), 2003,26(3):132-138
2. Asthma Group of Respirology Branch of Chinese Medical Association. Prevention Guide of Bronchial Asthma (including definition, diagnosis, treatment and management of bronchial asthma). Zhong Hua Jie He He Hu Xi Za Zhi (Chinese), 2008,31(3):177-185
3. Horiguchi S, Okamoto Y, Yonekura S, et al. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis. Int Arch Allergy Immunol, 2008,146(1): 76-84 (Pubitemid 351562946)
4. Tazaki T, Minoguchi K, Yokoe T, et al. Allergen rush immunotherapy increases interleukin (IL)-12 production and IL-12 receptor beta2 chain expression in patients with allergic asthma. Cell Immunol, 2004,228(1):20-26 (Pubitemid 38760119)
5. Dehlink E, Eiwegger T, Gerstmayr M, et al. Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in children. Clin Exp Allergy, 2006,36(1):32-39
6. Wang ZX, Li WJ. Starting time of the effect of specific immune curative treatment, Chinese journal of hospital pharmacy, 2009,29(19):1688-1689
7. Cosmi L, Santarlasci V, Angeli R. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin- 10-production. Clin Exp Allergy, 2006,36(3):261-272 (Pubitemid 43344707)
8. Rolinck-Werninghaus C, Kopp M, Liebke C. Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen. Int Arch Allergy Immunol, 2005,136(2):134-141 (Pubitemid 40463237)
9. Ciprandi G, De Amici M, Murdaca G, Serum IL-4 as a marker of immunological response to sublingual immunotherapy. J Biol Regul Homeost Agents, 2008, 22(2): 117-123
10. Savolainen J, Nieminen K, Laaksonen K, et al. Allergen- induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy. Allergy, 2007,62(8):949-953 (Pubitemid 47037859)